Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-17-036847
Filing Date
2017-07-14
Accepted
2017-07-14 16:52:45
Documents
5
Period of Report
2017-07-14

Document Format Files

Seq Description Document Type Size
1 PRE 14A v470849_pre14a.htm PRE 14A 630067
2 GRAPHIC card1.jpg GRAPHIC 142136
3 GRAPHIC card2.jpg GRAPHIC 96392
4 GRAPHIC card3.jpg GRAPHIC 87287
5 GRAPHIC card4.jpg GRAPHIC 95095
  Complete submission text file 0001144204-17-036847.txt   1211241
Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130
Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37544 | Film No.: 17965932
SIC: 2836 Biological Products, (No Diagnostic Substances)